Prometheus MedTech.AI selected to Top 40 out of 2,626 startups worldwide in Korea’s K-Startup Grand Challenge 2025!

Prometheus MedTech.AI has been named one of the Top 40 most promising startups in the prestigious K-Startup Grand Challenge 2025 (KSGC) — Korea’s leading international startup acceleration program.

From 2,626 applications representing 169 countries, only 40 companies were selected to advance. This recognition highlights not only the global potential of our technology, but also our exceptional commercialization strategy for bringing AI-driven cardiac screening to healthcare systems worldwide.

Why this matters

KSGC is one of the world’s most competitive and respected startup competitions, positioning Korea as a global hub for innovation. For Prometheus, being chosen among the Top 40 confirms the urgency and relevance of our mission:

• Every child deserves a chance at a healthy life.
• Early detection of congenital heart defects (CHDs) makes that possible.
• AI makes it scalable, accessible, and affordable.

What’s next

As part of this stage, we will participate in The Global Startup in Jeju (September 1–5, 2025), held in parallel with the APEC Global Startup Side Event and the Small and Medium Enterprises Ministerial Meeting (SMEMM). This unique platform will:

• Strengthen KSGC’s global reach
• Support rapid adaptation to the Korean business environment
• Provide high-level networking with investors, policymakers, and ecosystem partners

This opportunity not only validates our innovation but also accelerates our mission of bringing Ultra Echo Scan (UES)— the world’s first AI-based screening test for early CHD detection — into clinical practice across Asia and beyond.

Representing Prometheus in Korea

Our CEO APAC, Piotr Ściegienka, will represent Prometheus MedTech.AI in Korea, engaging with local stakeholders to drive market entry and integration of our technology into the healthcare system.

This is a major step forward on our journey — and we’re just getting started. Stay tuned on LinkedIn as we continue to shape the future of neonatal care with AI.